EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting MIF attenuates bleomycin-induced pulmonary fibrosis by inhibiting succinate accumulation

Hai Bing Lan, Hui Wang, Lin Lin Deng, Li Xia Xie, Jian Ning Xu

Frontiers in Physiology · 17.11.2026 · 17

DOI: 10.3389/fphys.2026.1960967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 17.11.2026. Verfasst von Hai Bing Lan und 4 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary fibrosis is a devastating disease with limited therapeutic options. Macrophage migration inhibitory factor (MIF) has been implicated in fibrogenesis, but its metabolic regulatory mechanisms remain unclear.

Methods

We established a bleomycin (BLM)-induced pulmonary fibrosis mouse model and TGF-β1-stimulated primary lung fibroblasts. MIF was inhibited in vivo using a MIF-targeting shRNA lentivirus (shMIF) or the pharmacological inhibitor (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), and in vitro using ISO-1. Fibrotic progression, aerobic glycolysis, PHD expression, HIF-1α protein levels, and succinate accumulation were assessed.

Results

MIF inhibition reduced aerobic glycolytic flux, as evidenced by decreased ECAR and lactate levels. Mechanistically, MIF downregulated PHD1/2 expression, increased HIF-1α protein levels, and promoted succinate accumulation under normoxic conditions, accompanied by enhanced fibrogenic responses.

Conclusion

These findings suggest that MIF promotes pulmonary fibrosis in association with the PISD-succinate-HIF-1α axis, potentially involving reduced PHD expression and increased HIF-1α protein levels. Rescue experiments further suggest that MIF promotes fibroblast activation at least in part through glycolysis-dependent mechanisms.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lan, H. B., Wang, H., Deng, L. L., Xie, L. X., & Xu, J. N. (2026). Targeting MIF attenuates bleomycin-induced pulmonary fibrosis by inhibiting succinate accumulation. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1960967

Vancouver

Lan HB, Wang H, Deng LL, Xie LX, Xu JN. Targeting MIF attenuates bleomycin-induced pulmonary fibrosis by inhibiting succinate accumulation. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1960967

BibTeX
@article{Lan2026,
  author = {Lan, Hai Bing and Wang, Hui and Deng, Lin Lin and Xie, Li Xia and Xu, Jian Ning},
  title = {Targeting MIF attenuates bleomycin-induced pulmonary fibrosis by inhibiting succinate accumulation},
  journal = {Frontiers in Physiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphys.2026.1960967}
}
Kostenlos starten →